Cargando…
Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704377/ https://www.ncbi.nlm.nih.gov/pubmed/34959483 http://dx.doi.org/10.3390/pharmaceutics13122059 |
| _version_ | 1784621693073883136 |
|---|---|
| author | Mudie, Deanna M. Stewart, Aaron M. Rosales, Jesus A. Adam, Molly S. Morgen, Michael M. Vodak, David T. |
| author_facet | Mudie, Deanna M. Stewart, Aaron M. Rosales, Jesus A. Adam, Molly S. Morgen, Michael M. Vodak, David T. |
| author_sort | Mudie, Deanna M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8704377 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87043772021-12-25 Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 Mudie, Deanna M. Stewart, Aaron M. Rosales, Jesus A. Adam, Molly S. Morgen, Michael M. Vodak, David T. Pharmaceutics Correction MDPI 2021-12-02 /pmc/articles/PMC8704377/ /pubmed/34959483 http://dx.doi.org/10.3390/pharmaceutics13122059 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Mudie, Deanna M. Stewart, Aaron M. Rosales, Jesus A. Adam, Molly S. Morgen, Michael M. Vodak, David T. Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 |
| title | Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 |
| title_full | Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 |
| title_fullStr | Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 |
| title_full_unstemmed | Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 |
| title_short | Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257 |
| title_sort | correction: mudie et al. in vitro-in silico tools for streamlined development of acalabrutinib amorphous solid dispersion tablets. pharmaceutics 2021, 13, 1257 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704377/ https://www.ncbi.nlm.nih.gov/pubmed/34959483 http://dx.doi.org/10.3390/pharmaceutics13122059 |
| work_keys_str_mv | AT mudiedeannam correctionmudieetalinvitroinsilicotoolsforstreamlineddevelopmentofacalabrutinibamorphoussoliddispersiontabletspharmaceutics2021131257 AT stewartaaronm correctionmudieetalinvitroinsilicotoolsforstreamlineddevelopmentofacalabrutinibamorphoussoliddispersiontabletspharmaceutics2021131257 AT rosalesjesusa correctionmudieetalinvitroinsilicotoolsforstreamlineddevelopmentofacalabrutinibamorphoussoliddispersiontabletspharmaceutics2021131257 AT adammollys correctionmudieetalinvitroinsilicotoolsforstreamlineddevelopmentofacalabrutinibamorphoussoliddispersiontabletspharmaceutics2021131257 AT morgenmichaelm correctionmudieetalinvitroinsilicotoolsforstreamlineddevelopmentofacalabrutinibamorphoussoliddispersiontabletspharmaceutics2021131257 AT vodakdavidt correctionmudieetalinvitroinsilicotoolsforstreamlineddevelopmentofacalabrutinibamorphoussoliddispersiontabletspharmaceutics2021131257 |